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bstract. Pneumonia in patients on the background of blood cancer. Pertseva T.A., Borisova I.S. Problematic 
issues of etiologic diagnosis and treatment of community-acquired and nosocomial pneumonia are being studied 
actively. At the same time specific features of pneumonia in patients with severe immune defects, against blood cancer 
including are studied insufficiently. By the result of microbiological examinations of 149 patients with pneumonia on 
the background of blood cancer, who have undergone treatment in hematological center of CE “Dnipropetrovsk local 
multi-field clinical hospital 4” in 2010-2012, bacterial causative agents were determined in 59,7% of accidents, 
among which gram-negative microorganisms made up 69,7%, gram-positive – 30,3%. In 63% of accidents the asso-
ciations of causative agents were determined: the combination of fungal flora made up 58, 4% bacterial associations – 
25, 8%. Invasive methods of research have demonstrated a considerably bigger informativeness in determination of 
possible etiological diagnosis of pneumonia. In determination of causative agent in fluid of brochoalveolar lavage the 
part of positive results made up 77,4% against 30,3% in examination of sputum. 
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 1  
n % 
 149 100 
 89 59,7 
56 37,6 
 17 19,1/30,3 
93 62,4 






 2  
n % 
Streptococcus neumoniae 7 7,9 
Streptococcus pyogenus 7 7,9 
Staphilococcus aureus 8 8,9 
Pseudomonas aeroginosa 11 12,3 
Hemophilla influenzae 6 6,7 
Escherichia coli 7 7,9 
Proteus spp.  8 8,9 
Enterobacter spp. 7 7,9 
7 7,9 
lebsiela neumoniae 4 4,5 
17 19,2 
89 100 
 62 ,  69,7%. 
27 ,  30,3%.  56 (62,9%) 
.
 52 (58,4%) ,
 23 (25,8%) 
.
Candida spp.;
Aspergillus spp.,  7 
(7,9%) .
,  S. neu-
moniae, H. influenzae, . neumoniae, -
 17 (19,1%) .
,
, P. 
aeroginosa, S. pyogenus, Staphilococcus aureus, 
 26 (29,2%) .
 Enterobacteriaceae (E.coli, Proteus 
vulgaris, Proteus mirabilis, Enterobacter spp.) -
 22 (24,7%) . -
 ( )




Serratia marcescens, Streptococcus 
viridans, Shewanella putrefaciens, Stenotropho-
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Abstract. Errors and complications in hip arthroplasty using cement technology. Loskutov O.E., 
Vasil'chenko E.V. According to the latest qualitative European registers cement type of fixation of one or both 
components of the hip joint is used in 4,5-58 % of cases, and in Scandinavian countries the figure is close to 90%. 
Performing any kind of surgery on musculoskeletal system surgeon should be prepared for post-operative com-
plications. This study presents analysis of errors and complications of 65 hip replacements using cement technology. 
The technical errors of hip replacement with cement technologies usage are: the uneven distribution of the cement 
